Monte-Carlo Simulation to Estimate the Health Care Costs Avoided With Fluticasone Furoate/Vilanterol Due to Exacerbation Rate Reduction in Spanish COPD Patients
Abstract
Authors
S. Mayoralas A. Huerta J. Parrondo C. Rubio-Terrés D. Rubio-Rodríguez